Abbott Laboratories
ABT
(New York Stock Exchange)

Recent

price

130.61

P/E

ratio

17.1

div

yld

1.75%

ROIC.AI

Capital Structure

in mil. unless spec.
Working Capital

in mil. unless spec.
Growth Rates

in mil. unless spec.
Quarterly Revenue

in mil. unless spec.
Quarterly Earnings Per Share

in mil. unless spec.
Quarterly Dividends Per Share

in mil. unless spec.
Similar Companies
Business
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Company News

  • AHCO or ABT: Which Is the Better Value Stock Right Now?

  • Molecular Infectious Disease Testing Market to Hit USD 17.78 Billion by 2029 with 13.7% CAGR | MarketsandMarkets™.

  • Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever.

  • ABT Stock Jumps 12% Since Q4 Earnings: Time to Invest in Abbott?

  • Investors Heavily Search Abbott Laboratories (ABT): Here is What You Need to Know

  • 3 No-Brainer Healthcare Stocks to Buy With $200 Right Now

  • Why We Chose Abbott Labs Stock Amid Tariff And DeepSeek Volatility

  • Here are the best performing dividend aristocrats stocks in 2025

  • Abbott's 'Above the Bias' Film Reveals Misconceptions Can Impact Diabetes Care

  • 2 Unstoppable Dividend Stocks That Will Pay You for Life

  • My Best Dividend Aristocrats For February 2025

  • Here is What to Know Beyond Why Abbott Laboratories (ABT) is a Trending Stock

  • Reasons to Retain ABT Stock in Your Portfolio Now

  • Expanding EPD Business Supports ABT Stock Amid Macro Issues

  • Is There More Upside For ABT Stock After A 10% Jump In A Week?

  • Abbott Laboratories: Strong Q4 Results And Bullish Outlook

  • Abbott Laboratories Will Outperform Healthcare Stocks in 2025

  • What Can The Dividend Kings Deliver In 2025?

  • Why Is Abbott Stock Trading Higher On Thursday?

  • Two Contrarian Dividends With Triple-Digit Potential For Trump 2.0